Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Cognitive Test Analysis May Determine Reliable MS Change Over Time
Safety and Clinical Outcomes of Rituximab Treatment in Patients with Multiple Sclerosis and Neuromyelitis Optica: Experience from a National Online Registry (GRAID).
[Usefulness of electronic drug registers: Spanish register of patients treated with fingolimod (Gilenya ®)].
Nancy Davis Foundation Annual MS Expo and Health Forum
IL-17 and Th17 Cells.
Best practice in the use of natalizumab in multiple sclerosis.
Management of worsening multiple sclerosis with mitoxantrone: a review.
Neuroprotection mediated through estrogen receptor-alpha in astrocytes.
The MS Microbiome Consortium (MSMC): an academic multi-disciplinary collaborative effort to elucidate the role of the gut microbiota in MS
Biogen Presents New Anti-LINGO-1 Phase 2 Acute Optic Neuritis Data Demonstrating Neurological Repair
Evaluation of No Evidence of Disease Activity in a 7-Year Longitudinal Multiple Sclerosis Cohort.
Treatment Choices in Optic Neuritis: Corticosteroids, Intravenous Immunoglobulin, Plasma Exchange, or Other?
Suppressed RNA-Polymerase 1 Pathway Is Associated with Benign Multiple Sclerosis.
Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination.
Therapeutic plasma exchange and pregnancy: A case report and guidelines for performing plasma exchange in a pregnant patient.
Teriflunomide modest help but safe for MS
Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study.
Experimental models of spontaneous autoimmune disease in the central nervous system.
Clinical Trials
Episode 1 with Dr. Timothy Vollmer on maintaining brain health
Demyelination of the hippocampus is prominent in the cuprizone model.
28th Congress of European Committee for Treatment and Research in Multiple Sclerosis Congress
FGF2 and FGFR1 signaling regulate functional recovery following cuprizone demyelination.
Sex differences in autoimmune disease.
Setting a research agenda for progressive multiple sclerosis: The International Collaborative on Progressive MS.

Pages